Cao Weiping, Wang Xinzhi, Chen Tingmei, Qin Mingmei, Wang Zuxian, Wang Qin, Xie Bing, Xu Wenlin
Department of Obstetrics, Maternity and Child Health Hospital of Zhenjiang, Zhenjiang.
Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing.
Medicine (Baltimore). 2019 Feb;98(6):e14301. doi: 10.1097/MD.0000000000014301.
Eclampsia is a life-threatening complication of pregnancy. Eclampsia is a leading cause of maternal and neonatal morbidity and mortality with most injury being associated with the seizures that mark the onset of the disease. It is vital that medical worker managing eclampsia have an understanding of the disease process.
A 28-year-old female, G4P1, with history of caesarean section was admitted at GA34+6, in addition to headache and severe hypertension (180/120 mm Hg) and proteinuria (+++). The evaluation of coagulation parameters showed positive D-dimer and increased fibrinogen and fibrinogen degradation product (FDP) and PT percent activity. Her biochemical analysis showed a decrease in total protein and an increase in alanine transaminase (ALT) and lactate dehydrogenase (LDH) and high serum uric acid and hyperlipidemia.
She was diagnosed with severe preeclampsia (PE).
First, the patient received magnesium sulfate therapy for convulsions control. Next, antihypertensive management of labetalol orally at a dose 100 mg and nifedipine orally at a dose 10 mg and glycerin trinitrate10 mg iv were used to maintain blood pressure in a safe range. Then, corticosteroid was given for enhancing fetal lung maturation. During preparation for cesarean section, the patient experienced suddenly seizures that lasted approximately 2 to 8 minutes. The immediate therapy is to stop the convulsions and reduce blood pressure.
The patient and her baby were discharged from the hospital on the 7th day after the operation with normal blood pressure and being in a satisfactory condition.
Eclampsia is defined as the occurrence of convulsions superimposed on the preeclampsia. The awareness of eclampsia enhances early diagnosis and timely administration of magnesium sulfate and calmative drug which are critical to avoid feto-maternal complications.
子痫是一种危及生命的妊娠并发症。子痫是孕产妇和新生儿发病及死亡的主要原因,大多数损伤与标志该病发作的惊厥有关。管理子痫的医务人员了解疾病过程至关重要。
一名28岁女性,孕4产1,有剖宫产史,孕34⁺⁶周入院,伴有头痛、重度高血压(180/120 mmHg)和蛋白尿(+++)。凝血参数评估显示D - 二聚体阳性、纤维蛋白原和纤维蛋白原降解产物(FDP)增加以及PT活性百分比升高。她的生化分析显示总蛋白降低、丙氨酸转氨酶(ALT)和乳酸脱氢酶(LDH)升高、血清尿酸高和高脂血症。
她被诊断为重度子痫前期(PE)。
首先,患者接受硫酸镁治疗以控制惊厥。其次,口服拉贝洛尔100 mg、硝苯地平10 mg以及静脉注射硝酸甘油10 mg进行降压管理,以将血压维持在安全范围内。然后,给予糖皮质激素以促进胎儿肺成熟。在准备剖宫产期间,患者突然发生惊厥,持续约2至8分钟。立即进行的治疗是停止惊厥并降低血压。
患者和她的宝宝在术后第7天出院,血压正常,状况良好。
子痫定义为在子痫前期基础上发生惊厥。对子痫的认识提高了早期诊断,并及时给予硫酸镁和镇静药物,这对于避免母婴并发症至关重要。